The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
We are committed to
- Accelerating curative therapies for multiple myeloma and related diseases through an integrated program of innovative research and high-quality, comprehensive patient care
- Customizing care based on each patient’s genetic profile and risk factors for truly personalized treatment
- Pushing the envelope of understanding and discovery to unravel the biology of multiple myeloma and maximize cure
Shannon Fleming, Ed.D., Named Executive Director of Development for UAMS Cancer InstituteDecember 12, 2018
Shannon Fleming, Ed.D., has been named executive director of development at the University of Arkansas for Medical Sciences (UAMS).
New Program at UAMS Offers Support to Children of Cancer PatientsSeptember 19, 2018
LITTLE ROCK - A new group to help children cope with a parent’s cancer diagnosis is set to begin Oct. 2 at the University of Arkansas for Medical Sciences (UAMS).
Nursing Student Interested in Research to Cycle for it via Ride for ResearchSeptember 11, 2018
UAMS nursing student Bethany Reinbolt, 31, was not familiar with myeloma before she read about the UAMS Myeloma Center’s Ride for Research set for Sept. 29.